Obesity and heart failure-the role of GLP-1 receptor agonists.

IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Herz Pub Date : 2025-08-01 Epub Date: 2025-04-02 DOI:10.1007/s00059-025-05312-2
Gregor Simonis, Ulrike Schatz
{"title":"Obesity and heart failure-the role of GLP-1 receptor agonists.","authors":"Gregor Simonis, Ulrike Schatz","doi":"10.1007/s00059-025-05312-2","DOIUrl":null,"url":null,"abstract":"<p><p>Patients with obesity-driven heart failure with preserved ejection fraction (HFpEF) often suffer from symptoms despite guideline-recommended treatment with diuretics, sodium glucose cotransporter 2 (SGLT2) inhibition, and mineralocorticoid antagonists. Obesity by itself drives heart failure via multiple pathophysiological mechanisms. This review summarizes current data on glucagon-like peptide‑1 (GLP-1) receptor agonists and the dual GIP/GLP‑1 agonist tirzepatide, including symptoms and outcomes in patients with obesity-driven HFpEF with or without diabetes.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"246-252"},"PeriodicalIF":0.9000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Herz","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00059-025-05312-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Patients with obesity-driven heart failure with preserved ejection fraction (HFpEF) often suffer from symptoms despite guideline-recommended treatment with diuretics, sodium glucose cotransporter 2 (SGLT2) inhibition, and mineralocorticoid antagonists. Obesity by itself drives heart failure via multiple pathophysiological mechanisms. This review summarizes current data on glucagon-like peptide‑1 (GLP-1) receptor agonists and the dual GIP/GLP‑1 agonist tirzepatide, including symptoms and outcomes in patients with obesity-driven HFpEF with or without diabetes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肥胖和心力衰竭- GLP-1受体激动剂的作用。
肥胖导致的射血分数保留型心力衰竭(HFpEF)患者尽管接受了指南推荐的利尿剂、钠葡萄糖共转运体 2(SGLT2)抑制剂和矿物质皮质激素拮抗剂治疗,但仍经常出现各种症状。肥胖本身通过多种病理生理机制导致心力衰竭。本综述总结了目前有关胰高血糖素样肽-1(GLP-1)受体激动剂和 GIP/GLP-1 双重激动剂替扎帕肽的数据,包括肥胖驱动的高频心力衰竭伴或不伴糖尿病患者的症状和预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Herz
Herz 医学-心血管系统
CiteScore
3.00
自引率
5.90%
发文量
61
审稿时长
4-8 weeks
期刊介绍: Herz is the high-level journal for further education for all physicians interested in cardiology. The individual issues of the journal each deal with specific topics and comprise review articles in English and German written by competent and esteemed authors. They provide up-to-date and comprehensive information concerning the speciality dealt with in the issue. Due to the fact that all relevant aspects of the pertinent topic of an issue are considered, an overview of the current status and progress in cardiology is presented. Reviews and original articles round off the spectrum of information provided.
期刊最新文献
[The 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease : A successful plea for psychocardiology]. [ESC Guidelines on cardiovascular diseases and pregnancy-most important facts of the 2025 update]. Bleeding risk associated with the co-use of direct oral anticoagulants and non-dihydropyridine calcium channel blockers: a meta-analysis. [ESC guidelines on dyslipidemia update 2025 : New recommendations for the practice]. [Cardiovascular imaging using cardiac computed tomography and cardiac magnetic resonance imaging].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1